LYTIR

Company · RANI

Rani Therapeutics Holdings, Inc.

Nasdaq's symbol directory lists RANI on Nasdaq as “Rani Therapeutics Holdings, Inc. - Class A Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($50K); insiders sold on 1 occasion ($301); 2 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $50K in total; Insider sales: $301 in total.Mar: Insider sales $301Jul: Insider purchases $50KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $50KInsider sales below: $301
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Talat Imran, Chief Executive Officer bought on 1 day latest Jul 17, 2026 bought $25K
  2. Mir A. Imran bought on 1 day latest Jul 21, 2026 bought $25K
  3. Javadi Alireza, Chief Technical Officer sold on 1 day latest Mar 27, 2026 sold $301
Every trade (3)
  1. BUYMir A. Imran bought Jul 21, 2026 36,000 shares filing $25K
  2. BUYTalat Imran, Chief Executive Officer bought Jul 17, 2026 35,000 shares filing $25K
  3. SELLJavadi Alireza, Chief Technical Officer sold Mar 27, 2026 386 shares filing $301

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. RA Capital Management, L.P. filed Aug 14, 2026 Schedule 13G/A passive filing 9.9%
  2. Vanguard Capital Management filed Jul 31, 2026 Schedule 13G/A passive 5,052,862 shares filing 4.49%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.